Quick Takeaways:
- Boehringer Ingelheim has partnered with Eko Health to launch Eko Vet+ | CANINEBEAT AI, an AI-powered solution designed to detect, visualize, and grade heart murmurs in dogs.
- The solution integrates three components: the Eko CORE digital stethoscope attachment that amplifies heart sounds up to 40x with noise cancellation, the CANINEBEAT AI algorithm trained on 4,000+ canine recordings, and the EkoVet+ app that generates visualizations, sound files, and shareable reports to support clinical decision-making and pet owner communication.
- With over 95% sensitivity and specificity in detecting murmurs linked to structural heart disease, the tool helps veterinarians identify subtle or early-stage conditions, such as myxomatous mitral valve disease, enabling earlier diagnosis and more timely treatment for improved canine health outcomes.
Why It Matters?
Boehringer Ingelheim and Eko are turning every canine auscultation into a structured, AI‑backed cardiac assessment, using Eko Vet+ | CANINEBEAT AI to detect and grade heart murmurs with over 95% sensitivity and specificity against murmurs linked to structural heart disease.
By combining the Eko CORE digital stethoscope attachment (40x amplification with noise cancellation), a canine‑specific algorithm trained on 4,000‑plus annotated recordings, and the EkoVet+ app that generates waveforms, sound files, and shareable reports, the solution helps vets pick up subtle or early myxomatous mitral valve disease and other conditions sooner, support data‑driven treatment decisions, and communicate risk more convincingly to pet owners at the primary‑care level.
Source: Globenewswire
